RAIN - Rain Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RAIN is currently covered by 6 analysts with an average price target of $6.94. This is a potential upside of $5.73 (473.55%) from yesterday's end of day stock price of $1.21.

Rain Therapeutics's activity chart (see below) currently has 7 price targets and 30 ratings on display. The stock rating distribution of RAIN is 65.22% BUY and 34.78% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 17.62% with an average time for these price targets to be met of 59.86 days.

Highest price target for RAIN is $1, Lowest price target is $1, average price target is $6.94.

Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 18-Sep-2023. First documented stock forecast 18-May-2021.

Currently out of the existing stock ratings of RAIN, 15 are a BUY (65.22%), 8 are a HOLD (34.78%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1

$-0.21 (-17.36%)

1.5

8 months 28 days ago

1/6 (16.67%)

$0.16 (19.05%)

28

Hold

1

$-0.21 (-17.36%)

17

1 years 10 days ago

1/5 (20%)

$-0.25 (-20.00%)

73

Hold

1 years 13 days ago

2/3 (66.67%)

$10.01 (111.35%)

90

Hold

1 years 23 days ago

0/1 (0%)

$9.77 (186.81%)

Hold

1.75

$0.54 (44.63%)

12

1 years 23 days ago

1/5 (20%)

$0.51 (41.13%)

228

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RAIN (Rain Therapeutics) average time for price targets to be met?

On average it took 59.86 days on average for the stock forecasts to be realized with a an average price target met ratio 17.62

Which analyst has the current highest performing score on RAIN (Rain Therapeutics) with a proven track record?

MITCHELL KAPOOR

Which analyst has the current lower performing score on RAIN (Rain Therapeutics) with a proven track record?

SOUMIT ROY

Which analyst has the most public recommendations on RAIN (Rain Therapeutics)?

Mitchell Kapoor has 15 price targets and 10 ratings on RAIN

Which analyst is the currently most bullish on RAIN (Rain Therapeutics)?

Michael Schmidt with highest potential upside - $18.79

Which analyst is the currently most reserved on RAIN (Rain Therapeutics)?

Graig Suvannavejh with lowest potential downside - -$0.21

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?